178 related articles for article (PubMed ID: 35709529)
21. Intracellular MHC class II controls regulatory tolerance to allogeneic transplants.
LeGuern C; Akiyama Y; Germana S; Tanaka K; Fernandez L; Iwamoto Y; Houser S; Benichou G
J Immunol; 2010 Mar; 184(5):2394-400. PubMed ID: 20100928
[TBL] [Abstract][Full Text] [Related]
22. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
23. Deletion of IRF8 (Interferon Regulatory Factor 8)-Dependent Dendritic Cells Abrogates Proatherogenic Adaptive Immunity.
Clément M; Haddad Y; Raffort J; Lareyre F; Newland SA; Master L; Harrison J; Ozsvar-Kozma M; Bruneval P; Binder CJ; Taleb S; Mallat Z
Circ Res; 2018 Mar; 122(6):813-820. PubMed ID: 29436389
[TBL] [Abstract][Full Text] [Related]
24. Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.
Jan M; Leventhal MJ; Morgan EA; Wengrod JC; Nag A; Drinan SD; Wollison BM; Ducar MD; Thorner AR; Leppanen S; Baronas J; Stevens J; Lane WJ; Kekre N; Ho VT; Koreth J; Cutler CS; Nikiforow S; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Lindsley RC; Ebert BL
Blood Adv; 2019 Jul; 3(14):2199-2204. PubMed ID: 31324640
[TBL] [Abstract][Full Text] [Related]
25. Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.
Williams O; Hu L; Huang W; Patel P; Bartom ET; Bei L; Hjort E; Hijiya C; Eklund EA
J Biol Chem; 2023 Jul; 299(7):104867. PubMed ID: 37247756
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia.
Pogosova-Agadjanyan EL; Kopecky KJ; Ostronoff F; Appelbaum FR; Godwin J; Lee H; List AF; May JJ; Oehler VG; Petersdorf S; Pogosov GL; Radich JP; Willman CL; Meshinchi S; Stirewalt DL
PLoS One; 2013; 8(8):e70812. PubMed ID: 23967110
[TBL] [Abstract][Full Text] [Related]
27. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.
Waldburger JM; Suter T; Fontana A; Acha-Orbea H; Reith W
J Exp Med; 2001 Aug; 194(4):393-406. PubMed ID: 11514597
[TBL] [Abstract][Full Text] [Related]
28. A genetic screen in macrophages identifies new regulators of IFNγ-inducible MHCII that contribute to T cell activation.
Kiritsy MC; Ankley LM; Trombley J; Huizinga GP; Lord AE; Orning P; Elling R; Fitzgerald KA; Olive AJ
Elife; 2021 Nov; 10():. PubMed ID: 34747695
[TBL] [Abstract][Full Text] [Related]
29. Chemical and genetic control of IFNγ-induced MHCII expression.
Wijdeven RH; van Luijn MM; Wierenga-Wolf AF; Akkermans JJ; van den Elsen PJ; Hintzen RQ; Neefjes J
EMBO Rep; 2018 Sep; 19(9):. PubMed ID: 30021835
[TBL] [Abstract][Full Text] [Related]
30. Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.
Sharma A; Yun H; Jyotsana N; Chaturvedi A; Schwarzer A; Yung E; Lai CK; Kuchenbauer F; Argiropoulos B; Görlich K; Ganser A; Humphries RK; Heuser M
Leukemia; 2015 Jan; 29(1):157-68. PubMed ID: 24957708
[TBL] [Abstract][Full Text] [Related]
31. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T; Velázquez GF; Schmid C
Mol Cancer; 2023 Nov; 22(1):180. PubMed ID: 37951964
[TBL] [Abstract][Full Text] [Related]
32. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
Kong J; Gao MG; Qin YZ; Wang Y; Yan CH; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
BMC Cancer; 2022 Jan; 22(1):11. PubMed ID: 34979982
[TBL] [Abstract][Full Text] [Related]
34. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
Mutis T; Schrama E; Melief CJ; Goulmy E
Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
[TBL] [Abstract][Full Text] [Related]
35. MHC class II expression through a hitherto unknown pathway supports T helper cell-dependent immune responses: implications for MHC class II deficiency.
Buch T; Polic B; Clausen BE; Weiss S; Akilli-Ozturk O; Chang CH; Flavell R; Schulz A; Jonjic S; Waisman A; Förster I
Blood; 2006 Feb; 107(4):1434-44. PubMed ID: 16254146
[TBL] [Abstract][Full Text] [Related]
36. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.
Cao Z; Budinich KA; Huang H; Ren D; Lu B; Zhang Z; Chen Q; Zhou Y; Huang YH; Alikarami F; Kingsley MC; Lenard AK; Wakabayashi A; Khandros E; Bailis W; Qi J; Carroll MP; Blobel GA; Faryabi RB; Bernt KM; Berger SL; Shi J
Mol Cell; 2021 Sep; 81(17):3604-3622.e10. PubMed ID: 34358447
[TBL] [Abstract][Full Text] [Related]
37. Exploiting a key transcriptional dependency: ZMYND8 and IRF8 in AML.
Taylor SJ; Sundaravel S; Steidl U
Mol Cell; 2021 Sep; 81(17):3445-3446. PubMed ID: 34478652
[TBL] [Abstract][Full Text] [Related]
38. Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.
Zhuang H; Li F; Xu Y; Pei R; Chen D; Liu X; Li S; Ye P; Yuan J; Lian J; Lu Y
Ann Hematol; 2023 May; 102(5):1063-1072. PubMed ID: 36959484
[TBL] [Abstract][Full Text] [Related]
39. Macrophage-specific MHCII expression is regulated by a remote
Buxadé M; Huerga Encabo H; Riera-Borrull M; Quintana-Gallardo L; López-Cotarelo P; Tellechea M; Martínez-Martínez S; Redondo JM; Martín-Caballero J; Flores JM; Bosch E; Rodríguez-Fernández JL; Aramburu J; López-Rodríguez C
J Exp Med; 2018 Nov; 215(11):2901-2918. PubMed ID: 30327417
[TBL] [Abstract][Full Text] [Related]
40. Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Deng DX; Wen JJ; Cheng YF; Zhang XH; Xu LP; Wang Y; Yan CH; Chen YH; Chen H; Han W; Wang FR; Wang JZ; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
BMC Cancer; 2021 Mar; 21(1):292. PubMed ID: 33740924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
